GARY S JACOB Insider Trading $SGYP SYNERGY PHARMACEUTICALS LLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY S JACOB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY S JACOB. GARY S JACOB is in Cardiff Oncology, Inc. ($XNOM.OB) and Director in Trovagene, Inc. ($XNOM.OB) and Chairman and CEO in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Chief Executive Officer in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Executive Chairman in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV) and Director in Virpax Pharmaceuticals, Inc. ($VRPX).
GARY S JACOB in SYNERGY PHARMACEUTICALS LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY S JACOB: Executive Chairman, Chairman and CEO, Chief Executive Officer
Holdings: 877,640 shares
Current Value: $5,371,157
Latest Transaction: Jun 18 2018
$SGYP Market Capitalization: $1.11B
$SGYP Previous Close: $6.12
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GARY S JACOB in SYNERGY PHARMACEUTICALS LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, HEPA, SGYP, VRPX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Option Exercise | M | 0.50 | 474,961 | 237,481 | 6,513,342 | |
| Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Payment of Exercise | F | 0.00 | 150,246 | 0 | 595,460 | 745.7 K to 595.5 K (-20.15 %) |
| Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Payment of Exercise | F | 0.00 | 131,934 | 0 | 745,706 | 877.6 K to 745.7 K (-15.03 %) |
| Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Buy | M | 0.50 | 474,961 | 237,481 | 877,640 | 402.7 K to 877.6 K (+117.95 %) |
| Jan 09 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Option Exercise | A | 2.18 | 950,000 | 2,071,000 | 6,988,303 | |
| Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chairman and CEO | Option Exercise | A | 1.40 | 900,000 | 1,260,000 | 6,038,303 | |
| Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chairman and CEO | Option Exercise | D | 1.40 | 900,000 | 1,260,000 | 5,138,202 | |
| May 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Buy | P | 3.52 | 5,680 | 19,967 | 402,679 | 397 K to 402.7 K (+1.43 %) |
| Jun 27 2016 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 3.67 | 970,000 | 3,559,900 | 5,905,177 | |
| Sep 30 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 5.39 | 500,000 | 2,695,000 | 4,935,177 | |
| Jul 28 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 7.91 | 300,000 | 2,373,000 | 4,435,177 | |
| Jul 01 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | M | 5.61 | 62,965 | 353,234 | 4,135,177 | |
| Jul 01 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Buy | M | 5.61 | 62,965 | 353,234 | 396,999 | 334 K to 397 K (+18.85 %) |
Page: 1